ArticleCureus2024
Natural History of Symptoms in Patients With Esophagogastric Junction Outflow Obstruction Using Standardized Surveys.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Our aim was to assess the clinical presentation and outcomes of patients with a manometric diagnosis of esophagogastric junction outflow obstruction (EGJOO) using standardized symptom surveys and comparison to a cohort who were referred for manometry but who had a normal study. Methods We followed a cohort of adult patients without a mechanical obstruction who underwent high-resolution manometry at our medical center from 9/12/19 to 10/4/21 for 16 months. Results Thirty-seven patients with EGJOO (age: 60.8 ± 13.3; female: 25/37) were compared to 33 patients with normal manometry (age: 57.6 ± 13.7; female: 21/33). For the untreated normal manometry group, there was a decrease in dysphagia scores at the six-month follow-up (10.8 ± 10.5 vs. 6.4 ± 10.4, P = 0.009) and a decrease in reflux scores at the 16-month follow-up (11.2 ± 3.0 vs. 7.8 ± 2.8, P = 0.042). For the untreated EGJOO group, there were no statistically significant changes in symptom scores. For both cohorts, dysphagia scores at the time of manometry had an inverse relationship with the change in dysphagia scores (EGJOO: r = -0.446, P = 0.033) (normal manometry: r = -0.464, P = 0.045). Conclusions Patients with EGJOO have a prognosis distinct from patients referred for manometry but who have a normal study and are likely to improve. However, even in patients with EGJOO, severe symptoms are likely to improve. Further investigation of therapies is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.